Physostigmine effects in Alzheimer's disease: Relationship to dementia severity
- 1 March 1986
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 38 (11), 1021-1028
- https://doi.org/10.1016/0024-3205(86)90236-5
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Oral physostigmine treatment of patients with Alzheimer's diseaseAmerican Journal of Psychiatry, 1985
- Oral physostigmine and lecithin improve memory in Alzheimer diseaseAnnals of Neurology, 1983
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983
- No effect from double‐blind trial of physostigmine and lecithin in Alzheimer diseaseAnnals of Neurology, 1983
- Oral Administration of Chronic Physostigmine does not Improve Cognitive or Mnesic Performances in Alzheimer's Presenile DementiaInternational Journal of Neuroscience, 1982
- Physostigmine and its effect on six patients with dementiaAmerican Journal of Psychiatry, 1981
- Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile DementiaThe British Journal of Psychiatry, 1981
- Effects of physostigmine and lecithin on memory in Alzheimer diseaseAnnals of Neurology, 1979
- Effect of Physostigmine on Constructional and Memory Tasks in Alzheimer's DiseaseArchives of Neurology, 1979
- PHYSOSTIGMINE IN ALZHEIMER'S DISEASEThe Lancet, 1979